Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Most patients start with every-other-night application for the first 1 to 2 weeks to minimize irritation from tretinoin, then increase to nightly use as tolerated
Factors such as individual health profile, treatment response, and tolerance levels influence the treatment plan
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
If you have MTHFR mutations and previous poor response to cyanocobalamin supplements, you might prefer a formulation containing methylcobalamin instead
Prior to the development and synthesis of modified peptide analogs, research into cellular aging and longevity relied largely on broad molecular signaling agents and nonspecific interventions
